Here’s a retraction from Stem Cells and Development that we’re just now getting around to covering. The paper, “Non-viral reprogramming of skeletal myoblasts with valproic acid for pluripotency,” appeared in June 2012 in a preliminary online form and was written by a group at the University of Cincinnati. As the retraction notice states: Continue reading Retraction for stem cell scientist facing misconduct inquiry
Category: stem cells dev
Embryonic stem cell paper retracted for fabrication
Stem Cells and Development has retracted a paper it published earlier this year after the leader of the study reported that the data were unreliable.
The paper, “Derivation and Genetic Modification of Embryonic Stem Cells from Disease-Model Inbred Rat Strains,” came from the lab of Aron Geurts, of the Medical College of Wisconsin.
According to the retraction notice: Continue reading Embryonic stem cell paper retracted for fabrication
Stem cell retraction leaves grad student in limbo, reveals tangled web of industry-academic ties
A contested retraction in Stem Cells and Development has left the Queensland University of Technology (QUT) graduate student who fought for it in limbo, uncertain if he will earn his PhD. And many of those who didn’t want the paper retracted have a significant financial interest in a company whose work was promoted by the research — despite any lack of disclosure in the now-retracted paper.
Here’s the notice: Continue reading Stem cell retraction leaves grad student in limbo, reveals tangled web of industry-academic ties